9 Meters Biopharma Inc reports results for the quarter ended in June - Earnings Summary

9 Meters Biopharma

12/08/2021 22:19

* 9 Meters Biopharma Inc  NMTR.OQ  reported a quarterly adjusted
loss of 3 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 3 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* 9 Meters Biopharma Inc's reported EPS for the quarter was a
loss of 3 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* 9 Meters Biopharma Inc shares had fallen by 3.6% this
quarter and gained 23.4% so far this year.
* The company reported a quarterly loss of $8.25 million.
* Wall Street's median 12-month price target for 9 Meters
Biopharma Inc is $5.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 09:19 p.m.  ​All
figures in US dollars unless otherwise stated